Organisation paid for research Program year 2022 Source: CMS Open Payments

Diagnamics Inc.

Neither a doctor nor a teaching hospital

Research payments

$314,342

116 payments

Through program year 2022, Diagnamics Inc. is reported as receiving $314,342 in research payments, across 116 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$17,000	7
2021	Research	$133,190	28
2020	Research	$67,609	21
2019	Research	$96,543	60

Breakdown

Who paid Research payments · program years 2019–2022

Abbott Laboratories $111,350 27 payments
Bayer HealthCare Pharmaceuticals Inc. $99,991 65 payments
AstraZeneca Pharmaceuticals LP $54,344 10 payments
Ironwood Pharmaceuticals, Inc $48,657 14 payments

Studies the money was for Research payments · program years 2019–2022

Peridot $98,700 25 payments
BAY1002670 Long term Safety vs SoC $89,960 57 payments
McP-103-205 $43,377 13 payments
A Randomized Double-Blind Parallel Group Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to Placebo and Open-label Spiriva Respimat in Subjects With Persistent Asthma $29,758 4 payments
A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler $14,271 2 payments
A Multicentre Randomized Double Blind Placebo Controlled Parallel Group Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma $10,315 4 payments
Bay1002670 Fibroids Efficacy US / EU $10,031 8 payments
SEFRIA Oral Fluid Collection $6,650 1 payment
Asd-08-033 $6,000 1 payment
McP-103-312 $5,280 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.